
In this Q&A, Christie Ballantyne, MD, explains why consistent LDL-C lowering with oral enlicitide could expand PCSK9 use in primary prevention.
Dr. Nichols thinks a shared savings model without a straight fee cut could be a promising solution to the sustainable growth rate.
Len Nichols, PhD, identifies the possible challenges that smaller cardiology practices may have when implementing patient-centered medical home models. Dr. Nichols also addresses the sustainable growth rate (SGR) formula and what solutions seem promising.